Lipoprotein(a) in Cardiovascular Diseases and Emerging Therapeutic Strategies
As novel therapies advance and clinical guidelines evolve, Lp(a) is emerging as a central determinant in personalized cardiovascular care. The increasing emphasis on Lp(a) testing underscores its importance in risk stratification and future therapeutic decisionmaking.
Authors
- Rami A. Al‐Horani (ORCID: https://orcid.org/0000-0001-9146-2662)
- Emily L. Smith
- Alexandra C. Selico-Dunn
Institutions
- Xavier University of Louisiana (US)
- Drexel University (US)
Publication Details
- Journal
- Cardiovascular Drugs and Therapy
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1007/s10557-025-07810-1
- Citations
- 1
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 2.01